Article Information
History
- December 23, 2021.
Article Versions
- Version 1 (November 9, 2021 - 12:55).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Robert Whittaker, (MSc)a,*,
- Anja Bråthen Kristofferson, (PhD)b,
- Beatriz Valcarcel Salamanca, (PhD)b,
- Elina Seppälä, (MD)a,
- Karan Golestani, (MD)c,
- Reidar Kvåle, (PhD)d,e,
- Sara Viksmoen Watle, (MD)a and
- Eirik Alnes Buanes, (PhD)d,f
- aDepartment of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway
- bDepartment of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway
- cDepartment of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway
- dDepartment of Anaesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway
- eDepartment of Clinical Medicine, University of Bergen, Bergen, Norway
- fNorwegian Intensive Care and Pandemic Registry, Haukeland University Hospital, Bergen, Norway
- ↵*Corresponding author: Robert Whittaker, Norwegian Institute of Public Health, Lovisenberggata 8, 0456, Oslo, Norway; Phone: +47 21 07 63 93; Email: Robert.Whittaker{at}fhi.no